Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Gazprom started supplying LNG to China via Africa

5/27/24 GAZP

Kazanorgsintez reported for 3 months of 2024 by RAS

5/27/24 KZOS

Shareholders of TMK approved dividends for 2023

5/24/24 TRMK

Board of Directors of Kazanorgsintez recommended that dividends be paid for 2023

5/24/24 KZOS

En+ Group to double its network of charging stations for electric vehicles by the end of 2024

5/24/24 ENPG

Europlan reports for the first quarter of 2024

5/24/24 LEAS

Sovcomflot reports for the first quarter of 2024

5/24/24 FLOT

Norilsk Nickel may start producing metal in Bahrain

5/24/24 GMKN

Moscow Exchange plans to conduct ten pre-IPO transactions before the end of the year

5/24/24 MOEX

Positive Technologie plans to gain a foothold in the cyber resilience market

5/24/24 POSI